Also trades as: ALK-B.CO (CPH) · $vol 5M · AKABY (OTC) · $vol 0M

$31.00

-0.20 (-0.64%)

Weekly Expected Move ±7.8%

$26 $29 $31 $33 $36

OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 43 · $6.2B mcap · 121M float · 0.0000% daily turnover · Short 100% of daily vol

Revenue

$6.3B +13.7% ▲

5Y CAGR: +12.5%

Gross Profit

$4.1B +16.8% ▲

5Y CAGR: +15.4%

Operating Income

$1.7B +52.1% ▲

5Y CAGR: +61.7%

Net Income

$1.2B +46.5% ▲

5Y CAGR: +116.7%

EPS (Diluted)

$5.41 +47.0% ▲

5Y CAGR: +118.0%

EBITDA

$2.0B +41.8% ▲

5Y CAGR: +39.1%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$3.9B	$4.5B	$4.8B	$5.5B	$6.3B
YoY Growth	+12.2%	+15.2%	+6.9%	+14.8%	+13.7%
Cost of Revenue	$1.5B	$1.7B	$1.8B	$2.0B	$2.1B
Gross Profit	$2.4B	$2.8B	$3.0B	$3.6B	$4.1B
Gross Margin	61.3%	61.9%	62.9%	64.2%	65.9%
R&D Expenses	$631M	$665M	$618M	$531M	$595M
SG&A Expenses	$1.5B	$1.7B	$1.8B	$1.9B	$1.9B
Operating Expenses	$2.1B	$2.3B	$2.4B	$2.5B	$2.5B
Operating Income	$292M	$470M	$666M	$1.1B	$1.7B
Operating Margin	7.5%	10.4%	13.8%	19.7%	26.3%
Interest Expense	$23M	$24M	$22M	$65M	$23M
Income Before Tax	$279M	$447M	$647M	$1.1B	$1.6B
Tax Expense	$60M	$112M	$161M	$242M	$437M
Net Income	$219M	$335M	$486M	$815M	$1.2B
Net Margin	5.6%	7.4%	10.1%	14.7%	19.0%
EPS (Diluted)	$0.99	$1.51	$2.20	$3.68	$5.41
EBITDA	$544M	$709M	$913M	$1.4B	$2.0B
Shares Outstanding	221M	221M	221M	222M	222M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$1.3B	$1.5B	$1.5B	$1.5B	$1.5B	$1.7B	$1.8B	$1.8B
Cost of Revenue	$471M	$545M	$506M	$532M	$487M	$552M	$544M	$598M
Gross Profit	$842M	$954M	$1.0B	$995M	$1.0B	$1.2B	$1.2B	$1.2B
Gross Margin	64.1%	63.6%	66.8%	65.2%	68.2%	68.1%	69.3%	66.6%
R&D Expenses	$109M	$167M	$129M	$146M	$145M	$189M	$151M	$167M
SG&A Expenses	$427M	$582M	$418M	$474M	$475M	$604M	$508M	$580M
Operating Expenses	$536M	$749M	$547M	$620M	$620M	$792M	$659M	$747M
Operating Income	$306M	$205M	$469M	$375M	$423M	$385M	$571M	$443M
Operating Margin	23.3%	13.7%	30.8%	24.6%	27.6%	22.3%	32.2%	24.8%
Interest Expense	$25M	$0	$0	$25M	$0	$0	$0	$0
Income Before Tax	$281M	$198M	$473M	$350M	$419M	$392M	$584M	$450M
Tax Expense	$69M	$28M	$119M	$87M	$105M	$127M	$146M	$113M
Net Income	$212M	$170M	$354M	$263M	$314M	$265M	$437M	$338M
Net Margin	16.1%	11.3%	23.3%	17.2%	20.5%	15.3%	24.7%	18.9%
EPS (Diluted)	$1.00	$0.76	$1.60	$1.20	$1.40	$1.21	$1.95	$1.50
EBITDA	$369M	$312M	$540M	$450M	$510M	$480M	$655M	$529M
Shares Outstanding	212M	223M	221M	219M	224M	222M	222M	222M

AKBLF OTC